NBRIC maps reagents, consumables makers for COVID-19 RT-PCR testing kits
11 May 2020 | News
NBRIC is a ‘A Make in India’ initiative for Biomedical research and innovative products
National Biomedical Resource Indigenisation Consortium (NBRIC) has been constituted by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India as a Public Private Partnership to drive indigenous innovation focused on developing reagents, diagnostics, vaccines and therapeutics for COVID-19.
NBRIC begins mapping of manufacturers of reagents and consumables for COVID-19 RT-PCR testing kits.
If you are an Indian or India-based manufacturer of reagents and consumables for COVID-19 RT-PCR testing kits, please register at https://bit.ly/2VcRnGl
The current call will build a nation-wide go-to repository for use by government and private organizations running RT-PCR tests.
Hosted and led by the Centre for Cellular and Molecular Platforms – C-CAMP, NBRIC aims to be a nation-wide collaborative platform for convergence of research, product resources and services towards developing reagents, diagnostics, vaccines, and therapeutics across India.
NBRIC is a ‘A Make in India’ initiative for Biomedical research and innovative products, towards promoting import substitution and exports.
The basic objectives of this initiative are to-
- Identify providers/manufacturing enterprises of crucial bio-medical resources
- Assess their current capabilities, capacities and requirements
- Support them by creating a enabling environment and connecting with policy makers and other stakeholders from public and private sectors
- Be the gateway for funding from DBT, BIRAC and DST for development or scaling
